Why Biotech And Pharma Patents Survive IPR
Why Biotech And Pharma Patents Survive IPR Law360 Full coverage
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
CleanSpark Announces Foundational Software Patent for Fractalgrid
CleanSpark Announces Foundational Software Patent for Fractalgrid POWER magazine Full coverage
-
In: PATENT NEWS
Volkswagen strikes deal with Broadcom to end patent lawsuit: source
Volkswagen strikes deal with Broadcom to end patent lawsuit: source Kitco News Volkswagen strikes deal with Broadcom to end patent lawsuit Nasdaq Full coverage
-
In: PATENT NEWS
Courts are trending toward broader patent eligibility
Courts are trending toward broader patent eligibility Food Dive Full coverage
-
In: PATENT NEWS
China’s top patent owners continue their overseas march
China’s top patent owners continue their overseas march IAM (blog) Full coverage
-
In: PATENT NEWS
Acting Attorney General Tied To Company Accused Of Patent Scams
Acting Attorney General Tied To Company Accused Of Patent Scams NPR Full coverage
-
In: PATENT NEWS
Motorola scores new German patent win against Hytera
Motorola scores new German patent win against Hytera Seeking Alpha Motorola Solutions Wins Second Patent Infringement Lawsuit Against Hytera Mobilfunk GmbH in Germany, Resulting in … Business Wire (press release) Second German Court Rules Hytera Infringed Motorola Patent RadioResource Media Group Full coverage
-
In: PATENT NEWS
Indivior shares slammed by Suboxone patent ruling
Indivior shares slammed by Suboxone patent ruling MarketWatch Full coverage
-
In: PATENT NEWS
Clovis Oncology announces second US patent issued in Rucaparib high dosage strength tablet
Clovis Oncology announces second US patent issued in Rucaparib high dosage strength tablet Seeking Alpha Clovis Oncology Announces Second US Patent Issued in Rucaparib High Dosage Strength Tablet Patent Family with … Business Wire (press release) Clovis Oncology (CLVS) Announces Second US Patent Issued in Rucaparib High Dosage Strength Tablet Patent Family StreetInsider.com... Continue reading
-
In: PATENT NEWS
GB Sciences Files First Of Its Kind Provisional Patent Application For The Treatment Of Neuropathic Pain Using Time …
GB Sciences Files First Of Its Kind Provisional Patent Application For The Treatment Of Neuropathic Pain Using Time … PRNewswire (press release) GB Sciences files patent application for the treatment of neuropathic pain using myrcene-based nanoparticles Seeking Alpha Full coverage